What should I Do? What should my patients Do?

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2019; 40(01): 3-4
DOI: 10.4103/ijmpo.ijmpo_31_19

Editorial Commentary

Purvish M Parikh

Department of Oncology, Shalby Cancer and Research Institute, Mumbai, Maharashtra, India

,

Padmaj Kulkarni

Department of Medical Oncology, Deenanath Mangeshkar Hospital, Pune, Maharashtra, India

References
1 Available from: https://www.omicsonline.org/open-access/pharma-regulations-for-generic-drug-products-in-india-and-us-case-studies-and-future-prospectives-2167-7689.1000119.php?aid=27336. [Last accessed on 2019 Jan 12].
2 What's the Difference Between Brand-Name and Generic Prescription Drugs? Scientific American. Available from: https://www.scientificamerican.com/article/whats-the-difference-betw-2004-12-13/ [Last accessed on 2019 Jan 12].
3 Parikh PM, Bhattacharyya GS, Hingmire SS, Mehta P, Rangrajan B, Natrajan G. et al. Our patient at risk from unauthorized, unapproved, illegally imported fake “generic medicines”. Indian J Med Sci 2018; 70: 43-7
4 Available from: https://www.jqknews.com/news/58523-Black_market_survey_of_overseas_anti-cancer_generic_drugs_some_manufacturers_even_say_they_are_counterfeit_drugs.html. [Last accessed on 2019 Jan 13].
5 Morris J, Philip S. Counterfeit Medicines in Less Developed Countries; 2006. Available from: http://www.policynetwork.net/sites/default/files/IPN_Counterfeits.pdf. [Last accessed on 2019 Jan 13].
6 Vial J, Cohen M, Sassiat P, Thiébaut D. Pharmaceutical quality of docetaxel generics versus originator drug product: A comparative analysis. Curr Med Res Opin 2008; 24: 2019-33